News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Manning Paul B
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
SC 13D/A
| Manning Paul B reports a 12.6% stake in Taysha Gene Therapies, Inc. |
| 08/16/2023 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 16,466,667 shares
@ $0.9, valued at
$14.8M
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2023 |
4
| Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 02/14/2023 |
3
| PD Joint Holdings, LLC Series 2016-A (10% Owner) has filed a Form 3 on Pasithea Therapeutics Corp. |
| 02/14/2023 |
SC 13G/A
| Manning Paul B reports a 9.3% stake in Liquidia Corporation |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/17/2022 |
4
| Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 07/15/2022 |
SC 13D
| Manning Paul B reports a 37.4% stake in Verrica Pharmaceuticals Inc. |
| 07/05/2022 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Bought 4,761,904 shares
@ $2.1, valued at
$10M
|
|
| 06/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
5/A
| Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend] |
| 04/20/2022 |
4
| Manning Paul B (Director) has filed a Form 4 on Liquidia Corp|
Txns:
| Granted 435,674 shares
@ $0 |
|
| 04/19/2022 |
4
| Manning Paul B (Director) has filed a Form 4 on Liquidia Corp|
Txns:
| Bought 392,156 shares
@ $5.1, valued at
$2M
|
|
| 02/14/2022 |
5
| Manning Paul B (10% Owner) has filed a Form 5 on Liquidia Corp |
| 02/14/2022 |
5
| Manning Paul B (10% Owner) has filed a Form 5 on Verrica Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G
| Manning Paul B reports a 9.9% stake in Acumen Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13D
| Manning Paul B reports a 13.6% stake in Candel Therapeutics, Inc. |
| 02/14/2022 |
5
| Manning Paul B (10% Owner) has filed a Form 5 on Candel Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Manning Paul B reports a 38.6% stake in Verrica Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| Manning Paul B reports a 10% stake in Liquidia Corporation |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2021 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 2,202 shares
@ $13.19, valued at
$29k
|
|
| 11/24/2021 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 20,000 shares
@ $12.54, valued at
$250.8k
|
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4/A
| Manning Paul B (10% Owner) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Converted 679,158 shares
@ $0
Converted 553,752 shares
@ $0
Bought 1,625,000 shares
@ $8, valued at
$13M
Converted 1,669,303 preferred shares
@ $0
Converted 1,361,069 preferred shares
@ $0 |
|
| 08/02/2021 |
4
| Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Converted 679,158 shares
@ $0
Converted 553,752 shares
@ $0
Converted 1,669,303 preferred shares
@ $0
Converted 1,361,069 preferred shares
@ $0 |
|
| 07/29/2021 |
4
| Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 36,000 shares
@ $7.3565, valued at
$264.8k
Bought 20,000 shares
@ $7.2972, valued at
$145.9k
|
|
| 07/26/2021 |
3
| Manning Paul B (Director) has filed a Form 3 on Candel Therapeutics, Inc. |
| 07/08/2021 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Converted 2,950,484 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 657,985 shares
@ $0
Converted 1,634,515 preferred shares
@ $0
Converted 1,315,969 preferred shares
@ $0
Converted 657,985 preferred shares
@ $0 |
|
|
|
|